Artículos del autor

solaci

Other

ESC 2020 | New Drug Improves Functional Capacity in Hypertrophic Cardiomyopathy

In patients with hypertrophic cardiomyopathy, myosin inhibitor mavacamten plus optimal medical therapy improved hemodynamics, functional capacity, and...
solaci -
Institutional News

The Most Read Articles of August in Interventional Cardiology

01- Myocardial Injury for COVID-19 Even in Young Patients with Mild Symptoms Most young COVID-19 patients not requiring...
solaci -
Other

ESC 2020 | Atrial Fibrillation and Rhythm Control: A Matter of Time?

Early rhythm control therapy in patients recently diagnosed with atrial fibrillation reduces the risk of cardiovascular events...
solaci -
ESC 2020

ESC 2020

Here are the most important articles of the Virtual ESC 2020. If you cannot view the articles, click...
solaci -
Acute coronary syndromes

Can Aspirin Use Be Interrupted After Angioplasty?

Aspirin discontinuation 1 to 3 months after angioplasty with continued P2Y12 inhibitor therapy reduces the bleeding risk without...
solaci -
Structural heart disease

3rd Generation Valves in Large and X-Large Annuli

In patients with large and extra-large annuli, transcatheter aortic valve replacement (TAVR) is safe and feasible with...
solaci -
Institutional News

3° ProEducar Educational Meeting – Complex Coronary Intervention

Watch again our Webinar on "Complex Coronary Intervention” on our Youtube account.  We are interested in your opinion....
solaci -
Coronary disease

SOLACI Webinar | Cardiac Arrhythmias

Watch again our Webinar on "Cardiac Arrhythmias” on our Youtube account.  We are interested in your opinion. Please,...
solaci -